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The Journal of Immunology
Composition, Development, and Function of Uterine Innate
Lymphoid Cells
Jean-Marc Doisne,* Elisa Balmas,*,†,1 Selma Boulenouar,*,†,1 Louise M. Gaynor,*,†
Jens Kieckbusch,*,† Lucy Gardner,†,‡ Delia A. Hawkes,* Cynthia F. Barbara,*
Andrew M. Sharkey,†,‡ Hugh J. M. Brady,x Jan J. Brosens,{ Ashley Moffett,†,‡ and
Francesco Colucci*,†
Innate lymphoid cells (ILCs), including NK cells, contribute to barrier immunity and tissue homeostasis. In addition to the role of
uterine NK cells in placentation and fetal growth, other uterine ILCs (uILCs) are likely to play roles in uterine physiology and
pathology. In this article, we report on the composition of uILCs in the endometrium during the luteal phase and in the decidua
during early pregnancy. Whereas nonkiller uILC1s and uILC2s are barely detectable in mouse and not detected in humans,
a sizeable population of uILC3s is found in human endometrium and decidua, which are mostly NCR+ and partially overlap with
previously described IL-22–producing uterine NK cells. Development of mouse uILC3 is Nfil3 independent, suggesting unique
features of uILCs. Indeed, although the cytokine production profile of mouse uILCs recapitulates that described in other tissues,
IL-5, IL-17, and IL-22 are constitutively produced by uILC2s and uILC3s. This study lays the foundation to understand how ILCs
function in the specialized uterine mucosa, both in tissue homeostasis and barrier immunity and during pregnancy. The Journal
of Immunology, 2015, 195: 3937–3945.
I
nnate lymphoid cells (ILCs) express transcription factors and
produce cytokines mirroring those of adaptive T cell subsets
(1–3). Group 1 ILCs (ILC1) include IFN-g–producing cells
that express T-bet, similarly to conventional NK cells (cNK). Unlike
cNK cells, nonkiller ILC1s do not express Eomes. Eomes-ve ILC1s
can be found in the spleen, liver (4), and intestine (5). Group 2 ILCs
(ILC2) include CD127 (IL-7Ra) and GATA-3–expressing cells
previously known as nuocytes, innate helper 2 cells, or natural
helper cells (6). ILC2s express ST2 (IL-33R) and IL-17RB (IL-25R)
and produce IL-5 and IL-13, but also amphiregulin, IL-9, IL-10,
IL-6, and little IL-4. They are found in fat-associated lymphoid
clusters, lymph nodes, intestine, and airways and are involved in
lung inflammation, airways hyperreactivity, and asthma. ILC2s also
participate in clearance of intestinal parasitic worms and in wound
healing after influenza infection. Group 3 ILCs (ILC3) express
RORgt and produce IL-17A and/or IL-22 (7). This group is com-
posed of three main classes in mice. One is CCR6+ lymphoid tissue
inducers (LTis), which orchestrate lymphoid organogenesis. CCR62
NCR+ ILC3s are found in the gut and produce IL-22, but not IL-
17A, playing a major role in gut immunity and mucosal homeo-
stasis. Upon stimulation with IL-12 and IL-18, NCR+ ILC3s can
downregulate RORgt, upregulate T-bet, and differentiate into ILC3-
derived ILC1s (8–10). CCR62NCR2 ILC3s have been also de-
scribed that can expand in the inflamed colon and produce IL-17A,
IL-22, and IFN-g (11).
The basic leucine zipper transcription factor Nfil3/E4BP4 was
reported as master regulator of NK cell differentiation (12, 13)
and was subsequently found to have a broader role in the immune
system (14). For example, Nfil3 is required for the development
of ILCs (15–17). Nfil32/2 mice exhibit defects in intestine, spleen,
and liver ILC1s, in lung, intestine, and adipose tissue ILC2s, as
well as in intestine and spleen ILC3s. Peyer’s patches (PP) and
cryptopatches are abnormal and not fully developed in Nfil32/2
mice, whereas lymph nodes appear normal (15–18). Interestingly,
tissue-resident NK (trNK) cells like liver, salivary glands, skin,
and uterus, as well as thymically derived NK cells, are present in
Nfil32/2 mice (19–21). Therefore, not all ILCs are dependent on
Nfil3 for development.
Immune cells are important for reproduction. NK cells, den-
dritic cells, macrophages, and regulatory T cells mediate key pro-
cesses (22), but other lymphoid cells may also contribute, including
ILCs (23). The human endometrium undergoes tissue remodeling
in each menstrual cycle and even more dramatically when the
mucosa decidualizes during pregnancy. Innate immune cells, in-
cluding uterine NK (uNK) cells and macrophages, are dominant in
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the decidua during pregnancy in both mice and humans (24) and
probably contribute to tissue homeostasis and preparation for
implantation. The decidua basalis is the site where fetal placental
trophoblast cells invade and interact with uNK cells. The probable
role of uNK cells is to remodel the uterine arteries during preg-
nancy (22, 25). Lymphoid aggregates (LA) mostly composed of
noncytotoxic CD8+ T cells form regularly in the basal layer of the
endometrium during the menstrual cycle in humans, although the
origin and function of LA is unclear (26).
In the virgin female mouse, the uterus is the most NK-rich
organ in the body with uNK cells representing up to 50% of
lymphocytes. During pregnancy, uNK cells continue to be a major
population and increase in absolute numbers, although less repre-
sented (20–30%). The role of uNK cells in mouse uterine vascular
remodeling and fetal-placental growth is well established (27). The
decidua proximal to the invading trophoblast is rich in uNK cells.
Distal to the trophoblast and in between the two smooth muscle
layers of myometrium (Myo) is the mesometrial LA of pregnancy
(MLAp), which is also rich in uNK cells. It is unclear how the
MLAp forms and develops and what its function may be (28).
A recent report described ILCs in human decidua (23). We
analyzed which ILCs are present in the nonpregnant human and
mouse endometrium and whether they change in composition and
function during pregnancy. We also studied the developmental
requirement of mouse uterine ILCs (uILCs), revealing uterine-
specific, Nfil3-independent ILC3s.
Materials and Methods
Mice
C57BL/6 mice were purchased from Charles River. Rag22/2 and Nfil32/2
mice were previously described (12, 29). Mice were used at 8–12 wk old
for tissue analysis or for time matings. All mice were bred at the University
of Cambridge Central Biomedical Service under pathogen-free conditions
and housed according to U.K. Home Office guidelines.
Human samples
Decidual biopsies were obtained from donors undergoing elective ter-
mination between 7 and 12 wk of pregnancy. The Cambridge Research
Ethics Committee approved this study (04/Q0108/23 and 08/H0305/40).
Endometrial biopsies were timed between 6 and 10 d after the preovu-
latory luteinizing hormone surge. All endometrial biopsies were obtained
in ovulatory cycles, and none of the subjects was on hormonal treatments
for at least 3 mo before the procedure. Subjects were recruited from the
Implantation Clinic, a dedicated research clinic at University Hospitals
Coventry and Warwickshire National Health Service Trust. The study was
approved by the National Health Service National Research Ethics–
Hammersmith and Queen Charlotte’s & Chelsea Research Ethics Committee
(1997/5065). Written, informed consent was obtained from all participants
in accordance with the guidelines in the Declaration of Helsinki (2000).
Tissue processing
Mouse uterus, spleen, liver, lung, PP, and lymph nodes were processed using
enzymatic protocol. Minced tissues were incubated 23 15 min with HBSS
(PAA), 10% FCS (Life Technologies), 5 mM EDTA (Sigma), 15 mM
HEPES solution (Life Technologies) on a rotator at 37˚C, then digested
during 30 min with RPMI 1640 containing 2% FCS, 30 mg/ml DNase I
(Roche), and 0.1 WU/ml Liberase DH (Roche). Digested tissues were
filtered and smashed with a syringe plunger on a cell strainer to mechani-
cally dissociate the remaining bits of tissues. Leukocytes were enriched on
an 80%/40% Percoll (GE Healthcare Life Sciences) gradient. Human de-
cidua and endometrium tissues were mechanically processed. Leukocytes
were enriched by layering on Lymphoprep (Axis-Shield).
Flow cytometry
Conjugated Abs anti-mouse CD45 (clone 30-F11), CD3ε (500A2 or 17A2),
CD19 (6D5), CD11b (M1/70), NK1.1 (PK136), NKp46 (29A1.4), CD90.2
(30-H12), ST2 (DIH9 and RMST2-2), ICOS (C398.4A), CD25 (PC61),
c-kit (2B8), Sca-1 (D7), IL-17RB (752101), CCR6 (29-2L17), IFN-g
(XMG1.2), IL-5 (TRFK5), IL-13 (eBio13A), IL-22 (Poly5164), IL-17A
(TC11-18H10.1), RORgt (Q31-378), Eomes (Dan11mag), and CD16/32-
Fc blocking (93); Abs anti-human CD45 (HI30), CD3 (UCHT1), CD19
(HIB19), CD14 (M5E2), CD127 (A019D5), CD9 (M-L13), CD56 (HCD56),
CRTH2 (BM16), c-kit (104D2), NKp44 (P44-8), RORgt (Q21-559) and
human Fc blocking; anti-human/mouse GATA-3 (TWAJ and 16E10A23)
and T-bet (O4-46) were purchased from Biolegend, eBioscience, BD
Biosciences, or R&D Systems. Cytokines and transcription factors were
stained using the Foxp3 staining buffer set (eBioscience) according to the
manufacturer’s instructions. Fixable viability dyes eFluor 780 and eFluor
506 (eBioscience) were used to exclude dead cells. Samples were acquired
on an LSR Fortessa (BD Biosciences) using FACSDiva and analyzed using
FlowJo (Tree Star).
Cytokine activation and intracellular staining
Isolated leukocytes were activated with 50 ng/ml PMA (Sigma) and 500
ng/ml Ionomycin (Sigma) during 4 h or with the following cytokines at
the indicated concentrations and incubation times at 37˚C: 10 ng/ml
recombinant murine IL (rmIL)-12 and 50 ng/ml rmIL-15, 50 ng/ml
rmIL-1b and 50 ng/ml rmIL-23 during 4 h in the presence of brefeldin
A (eBioscience) and monensin (Sigma); 20 ng/ml rmIL-25 and 20 ng/ml
rmIL-33 during 18 h, brefeldin A and monensin were added during the
last 6 h. All cytokines were purchased from Peprotech except rmIL-23
obtained from R&D Systems. Then cells were stained for cell-surface
markers, intracellular cytokines, and transcription factors.
Immunohistochemistry
Sections of cryoembedded uterine tissue from pregnant females at gesta-
tion day (gd) 9.5 were cut at 7 mm and fixed in acetone. Sections were
blocked with normal goat serum, followed by avidin and biotin blocking
solutions to minimize nonspecific binding. Sections were incubated with
anti-mouse CCR6-PE (29-2L17), CD127–Alexa Fluor 647 (A7R34), and
CD3-biotin (145-2C11) or isotype controls for 2 h at room temperature,
and for a further 30 min with streptavidin conjugated to Alexa Fluor 488
(Life Technologies). Sections were counterstained with DAPI. All Abs
were purchased from Biolegend except where indicated. Images were
acquired using a Leica SP5 confocal microscope and analyzed using
ImageJ software to adjust brightness and contrast.
Statistics
Two-tailed, unpaired or paired Student t test (GraphPad Prism 6) was used
to statistically analyze the data: *p # 0.05, **p , 0.01, ***p , 0.001,
****p , 0.0001. All data are expressed as means 6 SEM.
Results
uILC3s in the human uterine mucosa
We analyzed samples obtained from first-trimester decidua and
from endometrium of nonpregnant women during the luteal phase.
Tissues mechanically dissociated as enzymatic digestion resulted
in loss of CD56 and NKp44 expression (data not shown). Human
uNK cells have been extensively characterized and, therefore,
were not analyzed in this study. CD32CD192CD142CD127+ cells
were found in both endometrium and decidua and with similar
frequencies (Fig. 1). The vast majority of these cells expressed
RORgt, and thus belong to uILC3s (Fig. 1). NCR+ uILC3s was the
major subset, expressing also higher levels of CD56 compared
with NCR2 uILC3s (Fig. 1). Unlike mature uNK cells, uILC3s
were found to be c-kit+ and CD92. CD127+ uILC2s (CD562
RORgt2GATA-3hiCRTH2+) were detectable in three of five
samples at a very low frequency (,0.01%; data not shown). No
CD127+ uILC1s (RORgt2T-bet+) could be detected in these
samples (data not shown). These results demonstrate the presence
of a dominant population of NCR+CD127+ uILC3s, with a few
NCR2 cells. These data confirm a recent study analyzing ILCs in
the decidua (23) and show for the first time, to our knowledge, that
the uILC composition is similar in nonpregnant endometrium and
decidua.
Development of mouse uILC1s does not depend on Nfil3
Similarly to the human uterus, the wall of the virgin mouse uterus
comprises three layers: the endometrium lining the lumen, the Myo
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in the middle, and the outermost perimetrium (Supplemental Fig.
1). Besides subsets of uNK cells, which belong to the ILC1 family,
nothing is known about composition, development, and function
of other uILCs. Two classes of CD32NKp46+NK1.1+T-bet+ ILC1s
are known to be present in the virgin mouse uterus: CD49a+ trNK-
like cells and CD49a2DX5+ cNK-like cells (19). As in the liver,
development of uterine cNK-like, but not uterine trNK-like, cells
depends on Nfil3 (19). Similar to splenic cNK cells, uterine cNK-
like cells express Eomes and are hence termed uterine cNK cells
(Fig. 2A). Analysis of Eomes expression in the uterine CD49a+
trNK-like subset revealed two different populations. In contrast
with liver trNK cells, the largest subset surprisingly expressed
Eomes, named Eomes+ uterine trNK cells (Fig. 2A). Uterine trNK
cells are therefore different from Eomes2 liver trNK cells but
similar to Eomes+ thymic NK cells and salivary gland NK cells
(20, 21). The smallest subset of CD49a+ trNK-like cells did not
express Eomes and are hereafter defined as uILC1s (CD90.2+
T-bet+Eomes2) in the virgin uterine mucosa (Fig. 2A). uILC1s did
not express RORgt, whereas GATA-3 was expressed at an inter-
mediate level (data not shown). Therefore, uterine trNK-like NK
cells resemble liver T-bet+Eomes2 trNK cells marked by the ex-
pression of CD49a and lacking DX5 expression (Fig. 2A) (4, 30).
Once again, we found a striking difference compared with liver
T-bet+Eomes2 trNK cells (4), in that uterine T-bet+Eomes- ILC1s
do not express TRAIL (Fig. 2A). Furthermore, uILC1s did not
express CD127, similar to IEL ILC1s (Supplemental Fig. 2A)
(18). In Nfil32/2 mice, cNK cells were severely reduced in both
liver and spleen, whereas uILC1s were present and increased in
frequency and in absolute number, becoming the most abundant
subset within the CD49a+ cells (Fig. 2A). Altogether, these results
highlight the complexity of the ILC1s in the uterus, including at
least three subsets: uILC1s, trNK cells, and cNK cells.
Development of mouse uILC2s depends on Nfil3
uILC2s were present among the CD45+CD32CD192CD11b2
NK1.12NKp46-CD90.2+ cells in the virgin uterus (Fig. 2B) and
expressed GATA-3 as well as surface markers ST2, CD25, c-Kit,
Sca-1, IL-17RB, and, at intermediate levels, CD127 (Fig. 2B,
Supplemental Fig. 2A). uILC2s also expressed ICOS, which is,
however, also found on other CD90.2+ cells expressing low
GATA-3 (Supplemental Fig. 2B). The combined expression of
ST2 and GATA-3 may be the best strategy to define uILC2s. In
Nfil32/2 mice, uILC2s were severely reduced as previously de-
scribed in the lungs (Fig. 2B).
Development of mouse uILC3s does not depend on Nfil3
uILC3s were found in the virgin uterus and are identified as CD45+
CD32CD192CD11b2NK1.12CD90.2+RORgt+ cells (Fig. 2C).
The presence of uILCs in Rag22/2 mice demonstrates that their
presence is not the result of T cell contamination (Supplemental
Fig. 3). uILC3s expressed higher level of CD127 compared with
other uILCs (Supplemental Fig. 2A). A more in-depth analysis of
uILC3s revealed the presence of CCR6+ LTi-like cells and CCR62
NKp462 ILC3s in the virgin uterus, but no CCR62NKp46+ ILC3s
(Fig. 2C). In Nfil32/2 mice, as reported previously, the PP showed
marked reduction in number per mouse, in total cell number per
PP, and in size (Supplemental Fig. 4). We also found no ILC3s in
the PP, confirming previous studies showing that Nfil3 is required
for ILC3s and for the generation of the PP (Fig. 2C). Surprisingly,
however, both uILC3s and uterine LTi (uLTi)-like cells were present
and in normal numbers in the Nfil32/2 virgin uterus (Fig. 2C).
Mouse uILC2s and uILC3s are absent from the decidua
uILC1s could be found at midgestation in both Myo/MLAps and
decidua, albeit at lower frequencies compared with the virgin
uterus (Figs. 3A, 4A, Supplemental Fig. 1). uILC2s and uILC3s
were found in the Myo/MLAp, but not in the decidua (Fig. 3B,
3C); thus, uILC2s and uILC3s do not interact directly with the
trophoblast and instead sit deeper in the uterine wall (Fig. 4,
Supplemental Fig. 1). The frequency of uILCs at midgestation was
similar to that of the virgin uterus, suggesting that they did not
preferentially expand among leukocytes. However, we noticed
FIGURE 1. uILC3 is the major
subset in human endometrium and
decidua. Top panels show represen-
tative data from human endome-
trium (E) and decidua (D). CD127+
uILCs were gated on CD45+CD32
CD192CD142 cells and analyzed
for intracellular RORgt expression.
RORgt+ uILC3s were assessed for
NKp44, CD56, and c-kit expression.
Bottom panels show percentages of
CD127+ uILCs among leukocytes
(bottom left), RORgt+ uILC3s
among CD127+ cells (bottom mid-
dle), and NKp44+ among RORgt+
uILC3s (bottom right) in the E and
the D (n = 5 samples for each group,
mean, unpaired t test).
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a trend toward a higher percentage of uILC2s (p = 0.06) and
uILC3s (p = 0.10) in the Myo/MLAp compared with the virgin
uterus (Fig. 3B, 3C). To assess the distribution of uLTi-like cells,
we dissected the MLAp and the Myo apart and they were found to
contain similar frequencies of uLTi-like cells. Because of a high
concentration of lymphocytes in the MLAp, however, the absolute
number of uLTi-like cells was significantly higher in the MLAp
compared with the Myo (Fig. 3E). We then assessed the impact of
FIGURE 2. Composition of uILCs in the uterus of virgin WT and Nfil32/2 mice. (A) Left panel shows liver, spleen, and uterus CD49a+Eomes2 ILC1s
gated on CD45+CD32CD192NK1.1+NKp46+ cells in virgin WT and Nfil32/2 mice. Data are representative of four experiments. Top right panel shows
expression of DX5 and TRAIL on CD45+CD32CD192NK1.1+NKp46+CD90.2+T-bet+Eomes2WT uILC1s compared with WT splenic cNK cells and WT
liver T-bet+Eomes2 trNK cells, respectively. Data are representative of three experiments. Bottom right panel shows percentages among leukocytes and
absolute numbers of uILC1s in the uterus of WT (black) and Nfil32/2 (white) mice (n = 4 experiments, mean6 SEM, unpaired t test). (B) Left panel shows
GATA-3hiST2+ uILC2s gated on CD45+CD32CD192CD11b2NK1.12NKp462CD90.2+ cells from the uterus of virgin mice. Data are representative of 18
experiments.Middle panel shows expression of CD25, Sca-1, c-kit, and IL-17RB on uILC2s. Data are representative of five experiments. Right panels show
percentages among leukocytes and absolute numbers of ILC2s in the lungs (top panels) and the uterus (bottom panels) of WT (black) and Nfil32/2 (white)
mice (n = 2–6 experiments, mean6 SEM, unpaired t test). (C) Far left panel shows RORgt+CD127+ uILC3s gated on CD45+CD32CD192CD11b2NK1.12
CD90.2+ cells. Data are representative of 16 experiments. Middle left panels show expression of NKp46 (n = 16 experiments) and CCR6 (n = 5
experiments) on uILC3s compared with uterine Eomes+ NK cells. Middle right panels show percentages among leukocytes and absolute numbers of
uILC3s in the PP (top panels) and the uterus (bottom panels) of WT (black) and Nfil32/2 (white) mice (n = 2 experiments, mean 6 SEM, unpaired t test).
Far right panels show percentages among leukocytes (top panels) and absolute numbers (bottom panels) of uLTi-like cells in the uterus of WT (black) and
Nfil32/2 (white) mice (n = 2 experiments, mean 6 SEM, unpaired t test). *p # 0.05, **p , 0.01.
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FIGURE 3. Distribution of ILCs in the layers of the uterine wall of pregnant mice. (A) Left panel shows percentages of T-bet+Eomes2 uILC1s in the
uterine wall of virgin mice (V), compared with percentages in uterine layers of pregnant mice at midgestation, dissected out in Myo and MLAp together
(M) and decidua (D). Data are representative of six experiments. Right panels show percentages among leukocytes (left) and absolute numbers (right) of
uILC1s per mouse (n = 6 experiments, mean 6 SEM, unpaired t test). (B) Representative dot plots (left panel) show percentages of GATA-3hiST2+ uILC2s
in uterine layers of pregnant mice at midgestation, dissected as in (A). Data from virgin mice are shown in Fig. 2B. Data are representative of eight
experiments. Right panels show percentages among leukocytes (left) and absolute numbers (right) of uILC2s per mouse (n = 8 experiments, mean 6 SEM,
unpaired t test). (C) Top panels show percentages of RORgt+CD127+ uILC3s in uterine layers of pregnant mice at midgestation, dissected as in (A). Data
from virgin mice are shown in Fig. 2C. Data are representative of seven experiments. Bottom panels shows percentages among leukocytes (left) and
absolute numbers (right) of uILC3s per mouse (n = 7 experiments, mean 6 SEM, unpaired t test). (D) Histograms show expression of NKp46 (n = 12
experiments) and CCR6 (n = 3 experiments) on uILC3s from the Myo and the MLAp dissected together and compared with conventional uNK cells. (E)
Percentages among leukocytes (top panel) and absolute numbers (bottom panel) of CCR6+ uLTi-like cells per mouse in the isolated Myo and the isolated
MLAp dissected apart (n = 2 experiments, mean 6 SEM, paired t test). (F and G) Representative dot plots (left panel), percentages among leukocytes (top
right) and absolute numbers (bottom right) of GATA-3hiST2+ uILC2s (F) and RORgt+CD127+ uILC3s (G) in the MLAp at midgestation (gd9.5 to gd11.5) in
WT (black) and Nfil32/2 (white) mice (n = 3 experiments, mean 6 SEM, unpaired t test). *p # 0.05, **p , 0.01, ***p , 0.001, ****p , 0.0001.
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pregnancy on the development of uILC2s and uILC3s in the
MLAp of Nfil32/2 mice. uILC2s were present but at very low
percentages and numbers showing that pregnancy cannot rescue
their development (Fig. 3F). As in virgin mice, uILC3s are de-
tectable at a similar percentage to wild-type (WT) mice, but
numbers are significantly lower, reflecting the reduced numbers
of leukocytes in the MLAp of Nfil32/2 mice (Fig. 3G). In-
deed, Nfil32/2 mice display several defects during pregnancy
(S. Boulenouar, J.-M. Doisne, A. Sferruzzi-Perri, L.M. Gaynor,
J. Kieckbusch, E. Balmas, H.W. Yung, S. Javadzadeh, L. Volmer,
D.A. Hawkes, K. Phillips, H.J.M. Brady, A.L. Fowden, G.J. Burton,
A. Moffett, and F. Colucci, submitted for publication). Taken to-
gether, these data show that uILC1s are present in all layers of the
pregnant uterus, whereas uILC2s and uILC3s are confined deeper
within the muscle layer (Fig. 4). In addition, during pregnancy in
Nfil32/2 mice, uILC2 development is not rescued and uILC3s
decrease in numbers compared with pregnant WT mice.
Mouse uILC2s constitutively produce IL-5, but not IL-13, and
uILC3s constitutively produce IL-17 and IL-22
uILC1s produced IFN-g upon short stimulation in vitro with either
PMA and ionomycin or with IL-12 and IL-15 (Fig. 5A). Com-
pared with splenic cNK cells, fewer uILC1s produced IFN-g, al-
though the frequency of IFN-g+ upon stimulation increased at
midgestation (Fig. 5A).
uILC2s produced IL-5 constitutively in the virgin uterus and
more so by midgestation, whereas only a few uILC2s made IL-13
upon stimulation (Fig. 5B). uILC2s appeared to be the only source
of IL-5 either constitutively produced or induced after short ac-
tivation in the uterus, because we did not detect any other IL-5+
cells. IL-13 was not induced by IL-25 and IL-33 in the virgin
uterus, suggesting that uILC2s are possibly more responsive to
these cytokines during pregnancy because IL-13 production could
be induced in the Myo/MLAp. Alternatively, uILC2s may need
other cytokines, such as IL-2 or IL-7, to be fully activated. IL-13
was mainly expressed by IL-5–producing cells (Fig. 5B), and as
for IL-5, uILC2s were the only source of IL-13 in the uterus after
a short activation period.
uILC3s constitutively produced IL-17A and IL-22, unlike
ILC3s from peripheral lymph nodes (Fig. 5C). Production of
IL-17A and IL-22 was enhanced upon stimulation, especially for
IL-17A (Fig. 5C). Intriguingly, stimulation with PMA and ion-
omycin did not enhance IL-22 production, whereas stimulation
with IL-1b and IL-23 did (Fig. 5C). Uterine immune cells other
than uILC3s, for example, RORgt+CD3+ iNKT17 cells (31), were
also able to secrete IL-17 and IL-22 quickly in both virgin and
pregnant mice (data not shown).
Discussion
uNK cells are the likely key immune players at the maternal–
fetal interface and may also play roles in endometrial homeostasis
(22). The potential role of other ILCs in the uterus is unknown. We
have shown that only uILC3s are present in human endometrium
and decidua, whereas all three groups of murine ILCs are present
in the virgin uterus, as well as in the Myo and MLAps of dams at
midgestation. We also report in this article the discovery that
development of mouse uILC3s is not Nfil3 dependent, in contrast
with development of ILC3s present in other tissues, as previously
described. Functionally, we find that both uILC2s and uILC3s
constitutively produce IL-5 and IL-17/IL-22, respectively.
Nfil3 and uILC development
ILC development depends on Nfil3 (15–17), and we show in this
article that uILC2s are indeed dependent on Nfil3 similar to lung,
fat, and intestine ILC2s. These results suggest that ILC2 devel-
opment may be homogeneous and not tissue-specific. However,
during pregnancy, very few uILC2s can be detected. These re-
sidual uILC2s may expand by homeostatic proliferation, filling the
space left by the severe reduction in uNK cells in Nfil32/2 mice.
In contrast, both uILC1s and uILC3s are present in Nfil32/2 mice
with an increase in the Eomes2 uILC1s, a population that may
include developmentally arrested CD49a+Eomes+ trNK cells. In-
deed, Nfil3 is crucial for Eomes expression (32). The develop-
mental relationship among uILC1s, trNK, and cNK is unknown.
Some ILC1-like cells directly derive from NCR+ ILC3s (8–10),
but the lack of NCR+ ILC3s should exclude this possibility, al-
though fate-mapping experiments will be needed to test this (13).
Interestingly, we find both NCR2 and LTi-like uILC3s in Nfil32/2
mice, whereas ILC3s are absent in their PP. This could reflect
compensatory mechanisms in the uterine environment or a differ-
ent developmental pathway. For example, Eomes expression in the
uterus dominates over T-bet expression (33). During pregnancy,
uILC3s in Nfil32/2 mice do not expand to the same extent as in
WT mice, and in the future it will be of interest to test whether this
effect is intrinsic or caused by the changes in the cellular envi-
ronment, notably the severe reduction in uNK cells. Nfil3 is not
FIGURE 4. Distribution of uILCs in the uterus of virgin and pregnant
mice at midgestation. (A) The Myo and the MLAp contain uILC1, uILC2,
and uILC3 populations. Only uILC1s are identified in the decidua. All
three populations are also identified in the mesometrial tissue connecting
adjacent implantation sites. (B) Immunofluorescence staining of CCR6
(red), CD127 (blue), and CD3 (green) in mouse Myo at gd9.5. The pres-
ence of a CCR6+CD127+CD32 uLTi-like ILC3 is indicated by an arrow in
each fluorescence channel. Scale bar, 20 mm.
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required for extramedullary ILC1 development (21), and other
extramedullary ILC subsets may follow similar developmental
pathways, independent of Nfil3, whereas ILCs originating from
the bone marrow may be strictly dependent on Nfil3.
uILC1
A recent article described two putative CD1272 ILC1 subsets
in human decidua: CD56+T-bet+Eomes+ cells and CD562T-bet+
Eomes2 cells, which resemble the mouse uILC1s described in
this article (23). The identity of these cells is still undefined and
they might also be immature NK cells or ILC3-derived ILC1s. We
did not find CD127+ uILC1s in human endometrium or decidua.
However, we cannot exclude the presence of uILC1s in the basal
layer of the mucosa or in the Myo because of difficulties in
sampling these sites. The uILC1s detected in WT mice may be
immature NK cells, but this is unlikely because they are CD1272,
produce IFN-g, and are found in Nfil32/2 mice. IFN-g is a key
factor for arterial remodeling during pregnancy in mice (22).
Although uNK cells produce the most IFN-g in the uterus of
pregnant mice, uILC1s may also contribute to IFN-g production.
IFN-g produced by Eomes2 ILC1s upon cytokine stimulation
increases during pregnancy, reflecting a change in their activation
status and/or a more favorable microenvironment that induces
activation. Tbet2/2 mice, however, show normal spiral artery
remodeling (33). The role and function of Eomes+ trNK cells is
currently under investigation (S. Boulenouar et al., submitted for
publication).
uILC2
ILC2s were found deep in the uterine wall and not in human or
murine decidua, nor in human endometrium. Whether they are
present in human Myo, therefore, is still unknown, but there is no
FIGURE 5. Cytokine production
by uILCs. (A) Intracellular IFN-g in
cNK cells from the spleen and in
uILC1 from V, M, and D was mea-
sured upon stimulation ex vivo with
either PMA and ionomycin or IL-12
and IL-15. Left panel shows data for
gated uILC1s. Right panels show
percentages of IFN-g+ cells in stimu-
lated (S) or unstimulated (NS) uILC1s
(n = 3–6 experiments, mean 6 SEM,
unpaired t test). (B) Intracellular IL-5
and IL-13 in cells from V and M
were measured upon stimulation ex
vivo with either PMA and ionomycin
or IL-25 and IL-33. Top panels show
data for gated uILC2s. Bottom panels
show percentages of IL-5+ cells and
IL-13+ cells among S and NS uILC2s
(n = 2–6 experiments, mean 6 SEM,
paired t test). (C) Intracellular IL-17A
and IL-22 in cells from peripheral
lymph nodes (pLN); V and M were
measured upon stimulation ex vivo
with either PMA and ionomycin or
IL-1b and IL-23. Left panels show
data for gated uILC3s. Right panels
show percentages of IL-17A+ cells
and IL-22+ cells among S and NS
uILC3s (n = 2–6 experiments, mean6
SEM, paired t test). *p # 0.05, **p ,
0.01, ****p , 0.0001.
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equivalent structure to the MLAp in humans. In mice, uILC2s
constitutively produce IL-5, confirming findings using an IL-5
reporter mouse model, where ILC2s were shown to control eo-
sinophil homeostasis through an IL-5–dependent mechanism (34).
In mice, eosinophils may play a role in tissue remodeling of the
uterine mucosa (35) (although they are not present in humans),
and it will be interesting to study the relationship between uILC2s
and uterine eosinophils.
uILC2s respond to IL-25 and IL-33, both previously found in the
uterine mucosa during pregnancy. Lung ILC2s produce amphir-
egulin and GM-CSF, and these cytokines, if produced by uILC2s,
may also play important roles in uterine tissue remodeling and
trophoblast migration. IL-52/2 and IL-132/2 mice, however, do
not show any obvious phenotypes in pregnancy (35, 36).
uILC3
NCR+ uILC3s and LTi-like uILC3s are present in both human
endometrium and decidua with similar frequencies and with
similar phenotype, suggesting a stable uILC composition despite
the changes in the mucosa during decidualization. Similar to our
study, uILC3s were found in human decidua (23). Human uILC3s
are likely to include the IL-22–producing NK cells we described
previously and referred to then as stage 3 NK cells (37). Indeed,
these cells are CD92c-kit+CD127+, whereas CD56 and NKp44
are expressed heterogeneously. It will be interesting to dissect
the developmental relationship among stage 3 NK cells, NCR+
uILC3s, and LTi-like uILC3s. A recent article shows that AHR
inhibition in tonsil ILC3s induces NK cell differentiation, high-
lighting the close relationship between ILC3s and NK cells (38).
Along these lines, differentiation of IFN-g–producing uNK cells
was abnormal in AhR2/2 mice (39).
In mice, uILC3s comprise uLTi-like cells and NCR2 cells. The
lack of NCR+ ILC3s is surprising because it is thought that they
originate from NCR2 ILC3s. Mouse uLTi-like ILC3s are dis-
tributed throughout the uterine wall, including the MLAp. The
location of uLTi-like ILC3s, in proximity to uILC1s and uNK
cells, suggests that uLTi and uILC1s, besides uNK cells, may also
contribute to changes in the uterine vasculature during pregnancy
particularly as the main uterine vessels enter the uterine wall
through the MLAps in mice (Supplemental Fig. 1). Gut LTi cells
play a role in lymphoid organogenesis, and thus uLTi-like cells
could organize formation of MLAp in mice. However, LTa2/2
and LTbR2/2 pregnant mice do develop MLAp, although both
decidual development and cellularity of the MLAp are delayed in
both these mutant mice (28). Furthermore, no obvious uNK cell
defects were found in these mice (28), although a recent study
shows that ILC3s are able to support NK cell development
through LT-mediated stromal microenvironment (40). Other sol-
uble factors, such as IL-22, may play a role in the development
and maintenance of the MLAp. IL-22 has both proinflammatory
and tissue-protective roles in the gut and the skin. Moreover, along
with Th17 cells, uILC3s may promote survival, proliferation, and
invasion of human trophoblast during the first trimester of preg-
nancy (41, 42). uILC3s typically respond to IL-1b and IL-23,
known to be produced by macrophages and DCs. IL-1b can be
produced by human uterine macrophages and fetal trophoblast
(43, 44), whereas IL-23 produced by stromal cells is detected in
pregnant mice (44, 45).
We report in this article the presence of ILC3s in the human
uterus and the presence of all three groups of ILCs in the mouse
uterus where the development of uILC1s and uILC3s is Nfil3
independent. The differences in composition between human
and mouse uILCs may reflect the dramatic changes the mucosa
undergoes in the human menstrual cycle with cyclical degeneration
and renewal. In addition, we have only sampled the early stages
of pregnancy in humans and not later in gestation, and have not
been able to analyze immune cells in the basal layer of the
mucosa or Myo. In the future, it will be interesting to study the
developmental pathways of uILCs, their interactions with uterine
leukocytes, including NK cells and macrophages, as well as with
the uterine vasculature and stroma, and ultimately their role in
normal and pathological pregnancy.
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